Alaunos Therapeutics, Inc. - Common Stock TCRT 深 滬
等待開盤 09-10 09:30:00 美东时间
2.30
+0.110
+5.02%
華盛通- 最 高2.32
- 今 開2.245
- 成交量 2.76万股
- 最 低 2.1707
- 昨 收 2.19
- 總市值 377.09万
- 52周最高 6.20
- 市盈率 靜 --
- 換手率 1.68%
- 52周最低 1.3137
- 委 比 1.96%
- 總股本 163.95万
- 歷史最高 2239.50
- 量 比 0.52
- 振 幅 6.82%
- 歷史最低 1.3137
- 每 手 1
- 風險率 0.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
09-03 18:21
Alaunos Therapeutics Regains Nasdaq Compliance
Alaunos Therapeutics ( ($TCRT) ) has shared an update. On August 19, 2025, Alau...
08-21 05:50
Alaunos Therapeutics Q2 EPS $(0.63) Up From $(0.71) YoY
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 percent increase over losses of $(0.71) per share from the same period last year.
08-15 04:44
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
Alaunos Therapeutics Inc (($TCRT)) announced an update on their ongoing clinica...
08-13 00:13
Alaunos Therapeutics Announces Departure of Melinda Lackey
Alaunos Therapeutics ( ($TCRT) ) has provided an announcement. On July 16, 2025...
07-23 05:20
Alaunos Therapeutics Raises $850,000 in Private Offering
An announcement from Alaunos Therapeutics ( ($TCRT) ) is now available. On June...
06-26 21:18
Alaunos Therapeutics stock slides on $2M equity offering
Alaunos Therapeutics (NASDAQ:TCRT) shares fell over 14% premarket on Monday after the company launched an equity offering to raise around $2M in proceeds. The offering comprises 610,399 shares of comm...
06-23 20:45
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
Alaunos Therapeutics has completed a registered direct offering of approximately 610,399 shares at $3.36 per share, raising around $2.0 million to support its obesity program and general corporate initiatives. The offering, conducted under a 2022 SEC-registered shelf, is set to close on June 24, 2025, subject to customary conditions.
06-23 12:00
PMGC Capital Urges Alaunos Therapeutics To Accept Financing Term Sheet Previously Facilitated By Leading Wall Street Bank
PMGC Capital LLC ("PMGC Capital"), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB), today issued a public statement urging Alaunos Therapeutics, Inc. (NASDAQ:TCRT) to accept and act upon the term sheet
06-18 21:54
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., has urged Alaunos Therapeutics, Inc. to accept a term sheet facilitated by a leading Wall Street bank. PMGC Capital holds a significant ownership position in Alaunos and believes the proposed financing represents a compelling opportunity to maximize shareholder value. The term sheet, described as non-toxic and well-structured, provides substantial capital and potential value creation. PMGC Cap...
06-18 13:52
